{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910790791403321"]
[null,null,"Autore",null,"Bayless Theodore M. <1931->"]
[null,null,"Titolo",null,"Advanced therapy of inflammatory bowel disease . Volume 1 IBD and ulcerative colitics / / Theodore M. Bayless, Stephen B. Hanauer ; editor, Linda Mehta ; cover designer, Mary McKeon"]
[null,null,"Pubbl/distr/stampa",null,"Shelton, Connecticut : , : People's Medical Publishing House, , 2011"]
[{"$nulls":4},"©2011"]
[null,null,"ISBN",null,"1-60795-216-5"]
[null,null,"Edizione",null,"[Third edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (648 p.)"]
[null,null,"Disciplina",null,"616.3/44"]
[null,null,"Soggetti",null,"Inflammatory bowel diseases"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index at the end of each chapters."]
[null,null,"Nota di contenuto",null,"\"\"Advanced Therapy of IBD: Ulcerative Colitis (Volume 1) \"\"; \"\"Contents \"\"; \"\"Contributors \"\"; \"\"Preface \"\"; \"\"Acknowledgments \"\"; \"\"Tribute \"\"; \"\"Part I: Introduction \"\"; \"\"1: Expectations for the Patient with Ulcerative Colitis \"\"; \"\"2: Expectations for the Patient with Crohn's Disease \"\"; \"\"3: Living with Ulcerative Colitis \"\"; \"\"4: Living with Crohn's Disease \"\"; \"\"5: Interactions among the Pediatric Patient, His or Her Family, and the Doctor \"\"; \"\"6: Dealing with Teens with IBD \"\"; \"\"7: Psychosocial Concomitants of Pediatric IBD \"\"; \"\"8: Recognizing and Managing Patients Concerns \"\""]
[{"$nulls":4},"\"\"9: Benefits of Enhancing the Patient-Medical Professional Interface \"\"\"\"Part II: Etiology and Pathophysiology of IBD \"\"; \"\"10: IBD Pathogenesis: Current Concepts \"\"; \"\"11: IBD Genetics: Potential Clinical Relevance \"\"; \"\"12: Effect of Age of Onset on IBD Phenotypes and Genotypes \"\"; \"\"13: Environmental Influences in IBD \"\"; \"\"14: Biological Therapy in IBD \"\"; \"\"15: Addressable Pathophysiologic Alterations in the IBD Patient \"\"; \"\"16: Molecular Mechanisms of Colitis-Induced Cancer \"\"; \"\"Part III: Diagnostic/Prognostic Methodology \"\"; \"\"17: Clinical Subtypes in IBD \"\""]
[{"$nulls":4},"\"\"18: Computer Database for Patients with IBD \"\"\"\"19: Clinical Measures of Disease Activity \"\"; \"\"20: Useful Biological Markers as Activity Indices \"\"; \"\"21: The Role of Genetics and Serology in Diagnosing and Predicting the Natural History of IBD \"\"; \"\"22: Pediatric IBD: Presentations and Diagnosis, Including Serologies \"\"; \"\"23: Clinical Utility of Quallity of Life Measurements \"\"; \"\"24: Endoscopy in IBD \"\"; \"\"25: Magnifying "]
[{"$nulls":4},"Colonoscopy in IBD Patients \"\"; \"\"26: Endoscopic Biopsies \"\"; \"\"27: Crohn's Disease: CT Scanning in Clinical Decision Making \"\""]
[{"$nulls":4},"\"\"28: CT Enterography and Other Small Bowel Imaging \"\"\"\"29: Imaging IBD with FDG PET and PET/CT \"\"; \"\"30: Video Capsule Endoscopy and IBD \"\"; \"\"31: Transabdominal Bowel Sonography in Clinical Decision Making \"\"; \"\"32: Imaging Options in Perianal Crohn's Disease \"\"; \"\"Part IV: Aggravating Factors in IBD \"\"; \"\"33: IBD and Stress \"\"; \"\"34: \"\"Refractory\"\" IBD - A Misnomer? \"\"; \"\"35: Infectious Agents as Aggravating Factors in IBD \"\"; \"\"36: Viral Infections in IBD \"\"; \"\"37: Clostridium difficile and IBD \"\"; \"\"38: Nonsteroidal Anti-Inflammatory Drugs and IBD \"\"; \"\"39: Smoking and Crohn's Disease \"\""]
[{"$nulls":4},"\"\"40: Reducing Dietary Symptoms in Irritable Bowel Syndrome and IBD \"\"\"\"41: Coexisting Irritable Bowel Syndrome and IBD \"\"; \"\"42: Managing Irritable Bowel Syndrome and IBD in the Same Individual \"\"; \"\"43: Adverse Influences of Pregnancy on IBD \"\"; \"\"Part V: Medical Therapy of IBD \"\"; \"\"44: Pharmacogenomics in IBD \"\"; \"\"45:  The Placebo Response in IBD \"\"; \"\"46: Adherence Issues in the Management of IBD \"\"; \"\"47: Emerging Therapeutic Strategies for the Treatment of IBD: Mechanisms & Challenges \"\""]
[{"$nulls":4},"\"\"48: The Luminal Contents in IBD: What Clinicians Should Know About the Microbiota and its Manipulation \"\""]